MARKET

CKPT

CKPT

Checkpoint Therapeutics
NASDAQ
4.155
+0.005
+0.12%
Opening 13:11 05/14 EDT
OPEN
4.150
PREV CLOSE
4.150
HIGH
4.160
LOW
4.145
VOLUME
364.75K
TURNOVER
--
52 WEEK HIGH
4.500
52 WEEK LOW
1.500
MARKET CAP
361.57M
P/E (TTM)
-2.9312
1D
5D
1M
3M
1Y
5Y
1D
Lake Street Keeps Their Hold Rating on Checkpoint Therapeutics (CKPT)
TipRanks · 4h ago
Checkpoint Therapeutics GAAP EPS of -$0.19
Seeking Alpha · 19h ago
Checkpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 19h ago
*Correct: Checkpoint Therapeutics 1Q EPS 19c >CKPT
Dow Jones · 20h ago
*Correct: Checkpoint Therapeutics 1Q Loss/Shr 19c >CKPT
Dow Jones · 20h ago
*Correct: Checkpoint Therapeutics 1Q Loss $11.2M >CKPT
Dow Jones · 20h ago
Press Release: Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Dow Jones · 20h ago
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Barchart · 1d ago
More
About CKPT
More
Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. The Company is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-programmed death-ligand 1 (PD-L1) antibody licensed from the Dana-Farber Cancer Institute, as a potential new treatment for patients with selected recurrent or metastatic cancers, including metastatic and locally advanced cutaneous squamous cell carcinoma. The Company is also evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer. Its anti-GITR monoclonal antibody, CK-302, is a fully human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells.
Recently
Symbol
Price
%Change

Webull offers Checkpoint Therapeutics Inc stock information, including NASDAQ: CKPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CKPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CKPT stock methods without spending real money on the virtual paper trading platform.